Barcelona, Spain: Quality of life for women treated with a more targeted radiotherapy treatment – called accelerated partial breast irradiation – is at least as good as quality of life for women treated with standard radiotherapy, according to research presented at the ESTRO 37 conference and published simultaneously in The Lancet Oncology .
The treatment uses small tubes to deliver a higher dose of radiotherapy directly to the site of the tumour over a shorter period of time. Previous research shows that it is just as effective at treating early stage breast cancer as radiotherapy to the whole of the breast.
Researchers say the targeted treatment, which takes a week, is a good option for women with early breast cancer, especially those who would struggle with the three to six-week schedule of traditional radiotherapy.
The analysis of quality of life data was led by Dr Rebekka Schäfer, a clinician in the department of radiation oncology at University Hospital Würzburg, Germany. It involved more than 600 women treated at 16 hospitals across Europe who all had surgery to remove an early stage tumour.
Around half of the women received whole breast radiotherapy while the other half received the accelerated partial
Article originally posted at